Fundraising Fox

Metly

1 known investors

Metly is an AI-native pharma intelligence platform that aggregates internal and external data to search regulatory filings, clinical databases, and partnership signals, monitor competitors, and automatically update intelligence workflows. It serves pharma and biotech teams for competitive intelligence, business development, licensing, market access, and asset diligence, pairing its platform with therapeutic-area experts.

AI & Machine LearningBiotechSaaS

Investors · 1

Encomenda VCBarcelona · $108K – $540K

Funding

SEC filings, press & company announcements
  • Undisclosed amountpre-seed roundJul 2025 · 3 sources
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Metly raises €520K to accelerate pharma product.... - VJAL AI – Practical AI Training & Certification Programsvjal.ai · Jul 2025Metly Secures €520K Pre-Seed to Advance Pharma AI Partnershipsstartuphub.ai · Jul 2025Metly Raises €520K in Pre-Seed Round | The SaaS Newsthesaasnews.com · Jul 2025Metly raises €520K in a pre-seed round to accelerate pharma product launches with AI - Tech.eutech.eu · Jul 2025Metly Funding | Complete Analysis | Extruct AIextruct.ai

Frequently asked questions

What does Metly do?
Metly is an AI-native pharma intelligence platform that aggregates internal and external data to search regulatory filings, clinical databases, and partnership signals, monitor competitors, and automatically update intelligence workflows. It serves pharma and biotech teams for competitive intelligence, business development, licensing, market access, and asset diligence, pairing its platform with therapeutic-area experts.
Who are Metly's investors?
Metly's investors include Encomenda VC.